52
Avery Therapeutics, Inc. raises $8.5M under Reg D
Company raise · Raising · TUCSON, AZ · Form D filed 2026-09-21
$10M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Emile Nuwaysir | Director |
| Jordan Lancaster | Executive Officer, Director |
| Steven Goldman | Executive Officer |
| Lawrence Mehren | Director |
Signed by Jordan Lancaster, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.